Literature DB >> 15974950

Serine proteinase inhibitors in the skin: role in homeostasis and disease.

Hans-Jürgen Mägert1, Katrin Drögemüller, Michael Raghunath.   

Abstract

Serine proteinases fulfill and facilitate a broad spectrum of biological processes. They are held in check by different specific inhibitors. This delicate balance can be disturbed by genetic defects or exogenous influences and has been shown as the underlying or promoting cause for a large number of different diseases. For instance, proteinases are under investigation as drug targets for cancer, infections, neurodegenerative diseases, osteoporosis, inflammatory disorders and many more. Dermatological research has contributed greatly to the appreciation of the complex regulatory network between serine proteinases and serine proteinase inhibitors. In addition, proteolytically trimmed proteinase-activated receptors (PARs) trigger keratinocyte proliferation and differentiation as well as leukocyte attraction and activation. New insights have been gained particularly concerning the progression of inflammatory disorders of the skin. This review summarizes the role of serine proteinase inhibitors in physiology and pathophysiology of the skin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15974950     DOI: 10.2174/1389203054065374

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  4 in total

1.  Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models.

Authors:  Johann E Gudjonsson; Jun Ding; Andrew Johnston; Trilokraj Tejasvi; Andrew M Guzman; Rajan P Nair; John J Voorhees; Goncalo R Abecasis; James T Elder
Journal:  J Invest Dermatol       Date:  2010-03-11       Impact factor: 8.551

Review 2.  Innate immunity and antimicrobial defense systems in psoriasis.

Authors:  Amanda S Büchau; Richard L Gallo
Journal:  Clin Dermatol       Date:  2007 Nov-Dec       Impact factor: 3.541

3.  Differential effects of periopathogens on host protease inhibitors SLPI, elafin, SCCA1, and SCCA2.

Authors:  Lei Yin; Bryan Swanson; Jonathan An; Beth M Hacker; Gary A Silverman; Beverly A Dale; Whasun O Chung
Journal:  J Oral Microbiol       Date:  2010-05-04       Impact factor: 5.474

Review 4.  Pathogenic Mechanisms of Fusobacterium nucleatum on Oral Epithelial Cells.

Authors:  Sabine Groeger; Yuxi Zhou; Sabine Ruf; Joerg Meyle
Journal:  Front Oral Health       Date:  2022-04-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.